Schlossmacher MG - Search Results

1

Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.

Lieberman RL, Wustman BA, Huertas P, Powe AC Jr, Pine CW, Khanna R, Schlossmacher MG, Ringe D, Petsko GA. Lieberman RL, et al. Among authors: schlossmacher mg. Nat Chem Biol. 2007 Feb;3(2):101-7. doi: 10.1038/nchembio850. Epub 2006 Dec 24. Nat Chem Biol. 2007. PMID: 17187079

2

Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

Cullen V, Sardi SP, Ng J, Xu YH, Sun Y, Tomlinson JJ, Kolodziej P, Kahn I, Saftig P, Woulfe J, Rochet JC, Glicksman MA, Cheng SH, Grabowski GA, Shihabuddin LS, Schlossmacher MG. Cullen V, et al. Among authors: schlossmacher mg. Ann Neurol. 2011 Jun;69(6):940-53. doi: 10.1002/ana.22400. Epub 2011 Apr 6. Ann Neurol. 2011. PMID: 21472771

3

Dopamine covalently modifies and functionally inactivates parkin.

LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. LaVoie MJ, et al. Among authors: schlossmacher mg. Nat Med. 2005 Nov;11(11):1214-21. doi: 10.1038/nm1314. Epub 2005 Oct 16. Nat Med. 2005. PMID: 16227987

4

Amyloid beta-peptide is produced by cultured cells during normal metabolism.

Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, et al. Haass C, et al. Among authors: schlossmacher mg. Nature. 1992 Sep 24;359(6393):322-5. doi: 10.1038/359322a0. Nature. 1992. PMID: 1383826

5

Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.

Schlossmacher MG, Shimura H. Schlossmacher MG, et al. Methods Mol Biol. 2005;301:351-69. doi: 10.1385/1-59259-895-1:351. Methods Mol Biol. 2005. PMID: 15917645

6

The effects of oxidative stress on parkin and other E3 ligases.

LaVoie MJ, Cortese GP, Ostaszewski BL, Schlossmacher MG. LaVoie MJ, et al. Among authors: schlossmacher mg. J Neurochem. 2007 Dec;103(6):2354-68. doi: 10.1111/j.1471-4159.2007.04911.x. Epub 2007 Sep 19. J Neurochem. 2007. PMID: 17883392 Free article.

7

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.

Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ. Shimura H, et al. Among authors: schlossmacher mg. Science. 2001 Jul 13;293(5528):263-9. doi: 10.1126/science.1060627. Epub 2001 Jun 28. Science. 2001. PMID: 11431533

8

Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.

Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB, Myllykangas L, Schlossmacher MG, Tyynelä J. Cullen V, et al. Among authors: schlossmacher mg. Mol Brain. 2009 Feb 9;2:5. doi: 10.1186/1756-6606-2-5. Mol Brain. 2009. PMID: 19203374 Free PMC article.

9

beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms.

Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ. Haass C, et al. Among authors: schlossmacher mg. J Biol Chem. 1993 Feb 15;268(5):3021-4. J Biol Chem. 1993. PMID: 8428976 Free article.

10

Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain.

Baulac S, LaVoie MJ, Strahle J, Schlossmacher MG, Xia W. Baulac S, et al. Among authors: schlossmacher mg. Mol Cell Neurosci. 2004 Nov;27(3):236-46. doi: 10.1016/j.mcn.2004.06.014. Mol Cell Neurosci. 2004. PMID: 15519239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page